Unknown

Dataset Information

0

Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.


ABSTRACT: Background:ATP-binding cassette transporter super-family including ABCC1 and MDR-1 were involved in multi-drug resistance (MDR) of renal cell carcinoma (RCC) patients. Several miRNAs were confirmed to promote the MDR and the survival of tumor cells. Methods:The RCC cell lines Caki-2 with vinblastine-resistant (Caki-2/VBL) or doxorubicin-resistant (Caki-2/DOX) were constructed, respectively. The expressions of miR-210-3p, ABCC1 and MDR-1 protein were determined by qRT-PCR and Western blot assays. The viability of RCC cells was assessed by MTT assay. The regulatory relationship between miR-210-3p and ABCC1 was analyzed by Dual Luciferase assay. The effect of miR-210-3p in vivo was investigated with a tumor xenograft model in mice. Results:MiR-210-3p expression was observed to significantly decrease in Caki-2/VBL and Caki-2/DOX cells. Meanwhile, ABCC1 and MDR-1 were significantly increased in Caki-2/VBL and Caki-2/DOX cells. ABCC1 was a novel target of miR-210-3p and negatively regulated by miR-210-3p. And miR-210-3p improved drug-sensitivity of RCC cells. Down-regulation of ABCC1 could reverse the effect of miR-210-3p knockdown on the drug-resistance and the level of MDR-1 in drug-sensitive RCC cells. Conclusion:We confirmed that down-regulation of miR-210-3p increased ABCC1 expression, thereby enhancing the MRP-1-mediated multidrug resistance of RCC cells.

SUBMITTER: Li S 

PROVIDER: S-EPMC5803904 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.

Li Songchao S   Yang Jinjian J   Wang Jun J   Gao Wansheng W   Ding Yafei Y   Ding Yinghui Y   Jia Zhankui Z  

Cell & bioscience 20180207


<h4>Background</h4>ATP-binding cassette transporter super-family including ABCC1 and MDR-1 were involved in multi-drug resistance (MDR) of renal cell carcinoma (RCC) patients. Several miRNAs were confirmed to promote the MDR and the survival of tumor cells.<h4>Methods</h4>The RCC cell lines Caki-2 with vinblastine-resistant (Caki-2/VBL) or doxorubicin-resistant (Caki-2/DOX) were constructed, respectively. The expressions of miR-210-3p, ABCC1 and MDR-1 protein were determined by qRT-PCR and Weste  ...[more]

Similar Datasets

| S-EPMC5642499 | biostudies-literature
| S-EPMC4252025 | biostudies-literature
| S-EPMC6207099 | biostudies-literature
| S-EPMC5823652 | biostudies-literature
| S-EPMC5400553 | biostudies-literature
| S-EPMC4781857 | biostudies-literature
| S-EPMC7162877 | biostudies-literature
| S-EPMC7481213 | biostudies-literature
| S-EPMC5355269 | biostudies-literature
| S-EPMC9263027 | biostudies-literature